Literature DB >> 21873240

Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression.

Lixin Wang1, Joan S Brugge, Kevin A Janes.   

Abstract

Gene expression networks are complicated by the assortment of regulatory factors that bind DNA and modulate transcription combinatorially. Single-cell measurements can reveal biological mechanisms hidden by population averages, but their value has not been fully explored in the context of mRNA regulation. Here, we adapted a single-cell expression profiling technique to examine the gene expression program downstream of Forkhead box O (FOXO) transcription factors during 3D breast epithelial acinar morphogenesis. By analyzing patterns of mRNA fluctuations among individual matrix-attached epithelial cells, we found that a subset of FOXO target genes was jointly regulated by the transcription factor Runt-related transcription factor 1 (RUNX1). Knockdown of RUNX1 causes hyperproliferation and abnormal morphogenesis, both of which require normal FOXO function. Down-regulating RUNX1 and FOXOs simultaneously causes widespread oxidative stress, which arrests proliferation and restores normal acinar morphology. In hormone-negative breast cancers lacking human epidermal growth factor receptor 2 (HER2) amplification, we find that RUNX1 down-regulation is strongly associated with up-regulation of FOXO1, which may be required to support growth of RUNX1-negative tumors. The coordinate function of these two tumor suppressors may provide a failsafe mechanism that inhibits cancer progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873240      PMCID: PMC3189061          DOI: 10.1073/pnas.1103423108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  89 in total

1.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

2.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

Authors:  H Miyoshi; K Shimizu; T Kozu; N Maseki; Y Kaneko; M Ohki
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Metastasis results from preexisting variant cells within a malignant tumor.

Authors:  I J Fidler; M L Kripke
Journal:  Science       Date:  1977-08-26       Impact factor: 47.728

4.  Superoxide radical generation and Mn- and Cu-Zn superoxide dismutases activities in human leukemic cells.

Authors:  Masahiko Kato; Hisanori Minakami; Minoru Kuroiwa; Yasuyuki Kobayashi; Shigeru Oshima; Kunihisa Kozawa; Akihiro Morikawa; Hirokazu Kimura
Journal:  Hematol Oncol       Date:  2003-03       Impact factor: 5.271

5.  Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification.

Authors:  Taisuke Hosaka; William H Biggs; David Tieu; Antonia D Boyer; Nissi M Varki; Webster K Cavenee; Karen C Arden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

6.  From silencing to gene expression: real-time analysis in single cells.

Authors:  Susan M Janicki; Toshiro Tsukamoto; Simone E Salghetti; William P Tansey; Ravi Sachidanandam; Kannanganattu V Prasanth; Thomas Ried; Yaron Shav-Tal; Edouard Bertrand; Robert H Singer; David L Spector
Journal:  Cell       Date:  2004-03-05       Impact factor: 41.582

7.  Identification of RUNX1/AML1 as a classical tumor suppressor gene.

Authors:  Fernando P G Silva; Bruno Morolli; Clelia T Storlazzi; Luisa Anelli; Hans Wessels; Vladimir Bezrookove; Hanneke C Kluin-Nelemans; Micheline Giphart-Gassler
Journal:  Oncogene       Date:  2003-01-30       Impact factor: 9.867

8.  Akt activation promotes degradation of tuberin and FOXO3a via the proteasome.

Authors:  David R Plas; Craig B Thompson
Journal:  J Biol Chem       Date:  2003-01-06       Impact factor: 5.157

9.  Sequence specificity of the core-binding factor.

Authors:  I N Melnikova; B E Crute; S Wang; N A Speck
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

Review 10.  Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.

Authors:  Motomi Osato
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

View more
  68 in total

Review 1.  RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Authors:  Deli Hong; Andrew J Fritz; Jonathan A Gordon; Coralee E Tye; Joseph R Boyd; Kirsten M Tracy; Seth E Frietze; Frances E Carr; Jeffrey A Nickerson; Andre J Van Wijnen; Anthony N Imbalzano; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

2.  A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program.

Authors:  Shan Lin; Anetta Ptasinska; Xiaoting Chen; Mahesh Shrestha; Salam A Assi; Paulynn S Chin; Maria R Imperato; B J Aronow; Jingsong Zhang; Matthew T Weirauch; Constanze Bonifer; James C Mulloy
Journal:  Blood       Date:  2017-07-14       Impact factor: 22.113

Review 3.  Models of signalling networks - what cell biologists can gain from them and give to them.

Authors:  Kevin A Janes; Douglas A Lauffenburger
Journal:  J Cell Sci       Date:  2013-05-01       Impact factor: 5.285

4.  Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.

Authors:  Mi-Ryung Han; Jirong Long; Ji-Yeob Choi; Siew-Kee Low; Sun-Seog Kweon; Ying Zheng; Qiuyin Cai; Jiajun Shi; Xingyi Guo; Keitaro Matsuo; Motoki Iwasaki; Chen-Yang Shen; Mi Kyung Kim; Wanqing Wen; Bingshan Li; Atsushi Takahashi; Min-Ho Shin; Yong-Bing Xiang; Hidemi Ito; Yoshio Kasuga; Dong-Young Noh; Koichi Matsuda; Min Ho Park; Yu-Tang Gao; Hiroji Iwata; Shoichiro Tsugane; Sue K Park; Michiaki Kubo; Xiao-Ou Shu; Daehee Kang; Wei Zheng
Journal:  Hum Mol Genet       Date:  2016-06-27       Impact factor: 6.150

Review 5.  Posttranslational modifications of RUNX1 as potential anticancer targets.

Authors:  S Goyama; G Huang; M Kurokawa; J C Mulloy
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

6.  SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolism.

Authors:  Nicolas M Bertagnolli; Justin A Drake; Jason M Tennessen; Orly Alter
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

7.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

8.  Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma.

Authors:  Yan-Yi Jiang; De-Chen Lin; Anand Mayakonda; Masaharu Hazawa; Ling-Wen Ding; Wen-Wen Chien; Liang Xu; Ye Chen; Jin-Fen Xiao; William Senapedis; Erkan Baloglu; Deepika Kanojia; Li Shang; Xin Xu; Henry Yang; Jeffrey W Tyner; Ming-Rong Wang; H Phillip Koeffler
Journal:  Gut       Date:  2016-05-10       Impact factor: 23.059

Review 9.  New insights into the role of Runx1 in epithelial stem cell biology and pathology.

Authors:  Cornelia Johanna Franziska Scheitz; Tudorita Tumbar
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

10.  HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.

Authors:  Yanxin Pei; Kun-Wei Liu; Jun Wang; Alexandra Garancher; Ran Tao; Lourdes A Esparza; Donna L Maier; Yoko T Udaka; Najiba Murad; Sorana Morrissy; Huriye Seker-Cin; Sebastian Brabetz; Lin Qi; Mari Kogiso; Simone Schubert; James M Olson; Yoon-Jae Cho; Xiao-Nan Li; John R Crawford; Michael L Levy; Marcel Kool; Stefan M Pfister; Michael D Taylor; Robert J Wechsler-Reya
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.